Biotech & Pharma.T.A, Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A,

BIB 79.78

0.0%

Dec 31 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jibacoa who wrote (1977)	10/16/2007 9:27:00 AM
From: Jibacoa	Read Replies (1) of 3722

ANSV Is also acting well on pre-market. (up 9%) After some news. bigcharts.marketwatch.com AP Anesiva Says Zingo Effective in Study Tuesday October 16, 8:54 am ET Anesiva Says Data Show Zingo Eased Venous Access Pain in Adults in Late-Stage Study SOUTH SAN FRANCISCO, Calif. (AP) -- Drug developer Anesiva Inc. said Tuesday its pain treatment Zingo showed positive results in a late-stage study on patients receiving intravenous service or drawing blood through a needle. The PIII involved 699 adult patients. The drug is already approved for children ages 3 to 18 years and is expected to be commercially available in the second quarter of 2008. Anesiva plans to file a supplemental new drug application to use the product in adults with the Food and Drug Administration in the first quarter 2008. Snip It seems the stock may get back to the $15 level.<g> bigcharts.marketwatch.com Bernard

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next